Kiora Pharmaceuticals KPRX
NASDAQ KPRX
$2.57 +0.01 (+0.39%)
As of: Oct 1, 2026 · 10:34 AM EDT

Kiora Pharmaceuticals (KPRX) Net Margin (2016 - 2024)

Updated

Kiora Pharmaceuticals' Net Margin was 22.44% in FY2024.

Analysis

Kiora Pharmaceuticals (KPRX) Net Margin (2016 - 2024) Analysis & Trends

From FY2016 onward, Kiora Pharmaceuticals has reported Net Margin for 6 years.

  • Net Margin shows a five-year change of +286.65 percentage points (FY2019 to FY2024).
  • The FY2024 figure marks the highest annual Net Margin in data going back to FY2016.
  • Per Business Quant data, Net Margin in earlier years was -56901.65% in FY2020 (-56637.44 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 21.86%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 21.27%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -8.04%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 22.61%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 18.81%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 23.62%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -134.51%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 32.99%
10 Kiora Pharmaceuticals 15.81 Mn 15.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -11,108.23%
Mar 31, 2024 84.08%
Dec 31, 2020 -9,831.62%
Mar 31, 2019 32.42%
Sep 30, 2018 -993.27%
Jun 30, 2018 -1,148.81%
Mar 31, 2018 -217.09%
Sep 30, 2017 -5,542.96%
Jun 30, 2017 -2,243.48%
Mar 31, 2017 -1,582.19%
Dec 31, 2016 -2,307.83%
Sep 30, 2016 -1,231.06%
Jun 30, 2016 -1,629.70%
API Access

Kiora Pharmaceuticals Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=KPRX&period=max&api_key=YOUR_API_KEY